Literature DB >> 12756290

The caveolar nitric oxide synthase/arginine regeneration system for NO production in endothelial cells.

Larry P Solomonson1, Brenda R Flam, Laura C Pendleton, Bonnie L Goodwin, Duane C Eichler.   

Abstract

The enzyme endothelial nitric oxide synthase (eNOS) catalyzes the conversion of arginine, oxygen and NADPH to NO and citrulline. Previous results suggest an efficient, compartmentalized system for recycling of citrulline to arginine utilized for NO production. In support of this hypothesis, the recycling enzymes, argininosuccinate synthase (AS) and argininosuccinate lyase (AL), have been shown to colocalize with eNOS in caveolae, a subcompartment of the plasma membrane. Under unstimulated conditions, the degree of recycling is minimal. Upon stimulation of NO production by bradykinin, however, recycling is co-stimulated to the extent that more than 80% of the citrulline produced is recycled to arginine. These results suggest an efficient caveolar recycling complex that supports the receptor-mediated stimulation of endothelial NO production. To investigate the molecular basis for the unique location and function of endothelial AS and AL, endothelial AS mRNA was compared with liver AS mRNA. No differences were found in the coding region of the mRNA species, but significant differences were found in the 5'-untranslated region (5'-UTR). The results of these studies suggest that sequence in the endothelial AS-encoding gene, represented by position -92 nt to -43 nt from the translation start site in the extended AS mRNA 5'-UTRs, plays an important role in differential and tissue-specific expression. Overall, a strong evidential case has been developed supporting the proposal that arginine availability, governed by a caveolar-localized arginine regeneration system, plays a key role in receptor-mediated endothelial NO production.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12756290     DOI: 10.1242/jeb.00361

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  35 in total

1.  l-Citrulline and l-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits.

Authors:  Toshio Hayashi; Packiasamy A R Juliet; Hisako Matsui-Hirai; Asaka Miyazaki; Akiko Fukatsu; Jun Funami; Akihisa Iguchi; Louis J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

Review 2.  Arginase and vascular aging.

Authors:  Lakshmi Santhanam; David W Christianson; Daniel Nyhan; Dan E Berkowitz
Journal:  J Appl Physiol (1985)       Date:  2008-08-21

3.  Oncogenic Kaposi's Sarcoma-Associated Herpesvirus Upregulates Argininosuccinate Synthase 1, a Rate-Limiting Enzyme of the Citrulline-Nitric Oxide Cycle, To Activate the STAT3 Pathway and Promote Growth Transformation.

Authors:  Tingting Li; Ying Zhu; Fan Cheng; Chun Lu; Jae U Jung; Shou-Jiang Gao
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

4.  L-citrulline prevents alveolar and vascular derangement in a rat model of moderate hyperoxia-induced lung injury.

Authors:  Davide Grisafi; Evelyne Tassone; Arben Dedja; Barbara Oselladore; Valentina Masola; Vincenza Guzzardo; Andrea Porzionato; Roberto Salmaso; Giovanna Albertin; Carlo Artusi; Martina Zaninotto; Maurizio Onisto; Anna Milan; Veronica Macchi; Raffaele De Caro; Ambrogio Fassina; Michela Alfiero Bordigato; Lino Chiandetti; Marco Filippone; Patrizia Zaramella
Journal:  Lung       Date:  2012-03-20       Impact factor: 2.584

5.  Nitric oxide and cGMP mediate alpha1D-adrenergic receptor-Stimulated protein secretion and p42/p44 MAPK activation in rat lacrimal gland.

Authors:  Robin R Hodges; Marie A Shatos; Rachel S Tarko; Joanna Vrouvlianis; Jian Gu; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-08       Impact factor: 4.799

Review 6.  L-citrulline provides a novel strategy for treating chronic pulmonary hypertension in newborn infants.

Authors:  Candice D Fike; Marshall Summar; Judy L Aschner
Journal:  Acta Paediatr       Date:  2014-06-20       Impact factor: 2.299

7.  Pulmonary hypertension in the premature infant population: Analysis of echocardiographic findings and biomarkers.

Authors:  Michael G O'Connor; Divya Suthar; Kimberly Vera; James C Slaughter; Natalie L Maitre; Steven Steele; Amy Beller; Candice D Fike; Judy L Aschner; Paul E Moore; Eric D Austin
Journal:  Pediatr Pulmonol       Date:  2017-11-23

8.  Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes.

Authors:  Toshio Hayashi; Hisako Matsui-Hirai; Asaka Miyazaki-Akita; Akiko Fukatsu; Jun Funami; Qun-Fang Ding; Sumitra Kamalanathan; Yuichi Hattori; Louis J Ignarro; Akihisa Iguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

9.  Endothelial nitric-oxide synthase activation generates an inducible nitric-oxide synthase-like output of nitric oxide in inflamed endothelium.

Authors:  Jessica L Lowry; Viktor Brovkovych; Yongkang Zhang; Randal A Skidgel
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

10.  Argininosuccinate synthetase is a functional target for a snake venom anti-hypertensive peptide: role in arginine and nitric oxide production.

Authors:  Juliano R Guerreiro; Claudiana Lameu; Eduardo F Oliveira; Clécio F Klitzke; Robson L Melo; Edlaine Linares; Ohara Augusto; Jay W Fox; Ivo Lebrun; Solange M T Serrano; Antonio C M Camargo
Journal:  J Biol Chem       Date:  2009-06-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.